These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 29966179)

  • 1. 'Why don't I need a colonoscopy?' A novel approach to communicating risks and benefits of colorectal cancer screening.
    Emery JD; Pirotta M; Macrae F; Walker JG; Qama A; Jenkins M; Boussioutas A
    Aust J Gen Pract; 2018 Jun; 47(6):343-349. PubMed ID: 29966179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revised Australian national guidelines for colorectal cancer screening: family history.
    Jenkins MA; Ait Ouakrim D; Boussioutas A; Hopper JL; Ee HC; Emery JD; Macrae FA; Chetcuti A; Wuellner L; St John DJB
    Med J Aust; 2018 Nov; 209(10):455-460. PubMed ID: 30359558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CRISP-Q study: Communicating the risks and benefits of colorectal cancer screening.
    Kim GY; Walker JG; Bickerstaffe A; Hewabandu N; Pirotta M; Flander L; Jenkins M; Emery JD
    Aust J Gen Pract; 2018 Mar; 47(3):139-145. PubMed ID: 29621846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of appropriate colorectal cancer screening and preferences for receiving screening advice among people attending outpatient clinics.
    Dodd N; Mansfield E; Carey M; Oldmeadow C
    Aust N Z J Public Health; 2018 Aug; 42(4):334-339. PubMed ID: 29528551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of a multicentric colorectal cancer screening program in Chile].
    López-Kostner F; Zárate AJ; Ponce A; Kronberg U; Kawachi H; Okada T; Tsubaki M; Ito T; Nishikage T; Tanaka K; Kawano T; Eishi Y; Peñaloza P; Estela R; Karelovic S; Flores S
    Rev Med Chil; 2018 Jun; 146(6):685-692. PubMed ID: 30148899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of personalised risk information compared to a positive/negative result on informed choice and intention to undergo colonoscopy following colorectal Cancer screening in Scotland (PERICCS) - a randomised controlled trial: study protocol.
    Steele RJC; Digby J; Chambers JA; O'Carroll RE
    BMC Public Health; 2019 Apr; 19(1):411. PubMed ID: 30991987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colonoscopies in Australia - how much does the National Bowel Cancer Screening Program contribute to colonoscopy use?
    Worthington J; He E; Lew JB; St John J; Horn C; Grogan P; Canfell K; Feletto E
    Public Health Res Pract; 2023 Mar; 33(1):. PubMed ID: 36477980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
    Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limitations of the faecal occult blood test in screening for colorectal cancer.
    Delcò F; Sonnenberg A
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Quality and performance indicators of colorectal cancer screening pilot program in Csongrád County, Hungary].
    Kivés Z; Kovács A; Budai A; Döbrõssy L; Vajda R; Endrei D; Boncz I
    Magy Onkol; 2019 Jun; 63(2):125-132. PubMed ID: 31225536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenoma detection rates in an opportunistic screening colonoscopy program in Iran, a country with rising colorectal cancer incidence.
    Delavari A; Bishehsari F; Salimzadeh H; Khosravi P; Delavari F; Nasseri-Moghaddam S; Merat S; Ansari R; Vahedi H; Shahbazkhani B; Saberifiroozi M; Sotoudeh M; Malekzadeh R
    BMC Gastroenterol; 2014 Nov; 14():196. PubMed ID: 25404264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal cancer screening.
    Leggett BA; Hewett DG
    Intern Med J; 2015 Jan; 45(1):6-15. PubMed ID: 25582937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Multi-Level Fit-Based Quality Improvement Initiative to Improve Colorectal Cancer Screening in a Managed Care Population.
    Yu C; Skootsky S; Grossman M; Garner OB; Betlachin A; Esrailian E; Hommes DW; May FP
    Clin Transl Gastroenterol; 2018 Sep; 9(8):177. PubMed ID: 30177700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New trend in colorectal cancer in Germany: are young patients at increased risk for advanced colorectal cancer?
    Ambe PC; Jansen S; Zirngibl H
    World J Surg Oncol; 2017 Aug; 15(1):159. PubMed ID: 28835275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society.
    Wolf AMD; Fontham ETH; Church TR; Flowers CR; Guerra CE; LaMonte SJ; Etzioni R; McKenna MT; Oeffinger KC; Shih YT; Walter LC; Andrews KS; Brawley OW; Brooks D; Fedewa SA; Manassaram-Baptiste D; Siegel RL; Wender RC; Smith RA
    CA Cancer J Clin; 2018 Jul; 68(4):250-281. PubMed ID: 29846947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Centralised faecal blood testing for both screening and pathology requests.
    Edwards JB
    Pathology; 2010 Dec; 42(7):700-4. PubMed ID: 21080891
    [No Abstract]   [Full Text] [Related]  

  • 17. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition--Communication.
    Austoker J; Giordano L; Hewitson P; Villain P;
    Endoscopy; 2012 Sep; 44 Suppl 3():SE164-85. PubMed ID: 23012120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for colorectal cancer using the faecal occult blood test, hemoccult.
    Towler BP; Irwig L; Glasziou P; Weller D; Kewenter J
    Cochrane Database Syst Rev; 2000; (2):CD001216. PubMed ID: 10796760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal occult blood and flexible sigmoidoscopy screening for colorectal cancer: modeling the impact on colonoscopy requirements and cancer detection rates.
    Olynyk JK; Platell CF; Collett JA
    J Gastroenterol Hepatol; 2001 Apr; 16(4):389-92. PubMed ID: 11354276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of presenting information about invasive follow-up testing on individuals' noninvasive colorectal cancer screening participation decision: results from a discrete choice experiment.
    Benning TM; Dellaert BG; Severens JL; Dirksen CD
    Value Health; 2014 Jul; 17(5):578-87. PubMed ID: 25128051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.